The following article describes abnormalities in the mechanism of action of the JAK–STAT pathway implicated in selected genetic alterations associated with childhood B-ALL, alongside available and experimental therapeutic options. The gene discussed is SOAT1; the disease is precursor B-cell acute lymphoblastic leukemia.